REVANCE THERAPEUTICS INC shareholders Q2 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 27,384$6930.01%
Ameritas Investment Partners, Inc. 6,889$174,3610.01%
PUTNAM INVESTMENTS LLC 182,189$4,611,2030.01%
STATE OF WISCONSIN INVESTMENT BOARD 93,178$2,358,3350.01%
State of New Jersey Common Pension Fund D 78,397$1,984,2280.01%
Brookfield Asset Management 58,727$1,486,3800.01%
ExodusPoint Capital Management, LP 27,345$6920.01%
Connor, Clark & Lunn Investment Management Ltd. 44,001$1,113,6650.01%
AMERICAN INTERNATIONAL GROUP, INC. 40,154$1,016,2980.01%
METROPOLITAN LIFE INSURANCE CO/NY 4,557$115,3380.01%
Stephens Consulting, LLC 500$12,6550.01%
Leucadia National 23,000$582,1300.01%
COMMONWEALTH EQUITY SERVICES, LLC 95,651$2,4210.01%
Arizona State Retirement System 23,552$596,1010.01%
GEODE CAPITAL MANAGEMENT, LLC 1,695,510$42,913,3740.01%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 627,045$15,870,5090.01%
WELLINGTON MANAGEMENT GROUP LLP 1,045,289$26,456,2640.01%
BlackRock Inc. 6,526,588$165,187,9420.01%
DekaBank Deutsche Girozentrale 86,100$2,1420.01%
TEACHER RETIREMENT SYSTEM OF TEXAS 22,744$5760.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.